A detailed history of Concentric Capital Strategies, LP transactions in Albemarle Corp stock. As of the latest transaction made, Concentric Capital Strategies, LP holds 10,250 shares of ALB stock, worth $964,217. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,250
Previous 12,831 20.12%
Holding current value
$964,217
Previous $1.69 Million 42.07%
% of portfolio
0.05%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$92.77 - $135.46 $239,439 - $349,622
-2,581 Reduced 20.12%
10,250 $979,000
Q1 2024

May 14, 2024

BUY
$108.73 - $146.89 $1.19 Million - $1.61 Million
10,978 Added 592.44%
12,831 $1.69 Million
Q4 2023

Feb 14, 2024

SELL
$113.26 - $170.8 $416,910 - $628,714
-3,681 Reduced 66.52%
1,853 $267,000
Q3 2023

Nov 13, 2023

BUY
$162.63 - $243.44 $899,994 - $1.35 Million
5,534 New
5,534 $941,000

Others Institutions Holding ALB

About ALBEMARLE CORP


  • Ticker ALB
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 117,129,000
  • Market Cap $11B
  • Description
  • Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...
More about ALB
Track This Portfolio

Track Concentric Capital Strategies, LP Portfolio

Follow Concentric Capital Strategies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concentric Capital Strategies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Concentric Capital Strategies, LP with notifications on news.